PMA P070015S146

Device
XIENCE V and XIENCE Nano EVEROLIMUS ELUTING CORONARY STENT SYSTEMS
Applicant
Abbott Vascular, Inc.
PMA number
P070015
Supplement
S146
Product code
NIQ
Decision date
2020-03-19
Generic name
Coronary drug-eluting stent
Approval order statement
Approval for changing the ethylene oxide (EO) sterilization release process for the affected products from the traditional method of biological indicator testing to a parametric release process.

Current openFDA PMA Record#

Device
XIENCE V and XIENCE Nano EVEROLIMUS ELUTING CORONARY STENT SYSTEMS
Applicant
Abbott Vascular, Inc.
PMA number
P070015
Supplement
S146
Product code
NIQ
Generic name
Coronary drug-eluting stent
Decision date
2020-03-19
Decision code
APPR
Date received
2019-09-26
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Approval for changing the ethylene oxide (EO) sterilization release process for the affected products from the traditional method of biological indicator testing to a parametric release process.